Abstract
Herein we demonstrate that chronic simian immunodeficiency virus (SIV) infection induces significant upregulation of the gut-homing marker α4β7 on macaque NK cells, coupled with downregulation of the lymph node-trafficking marker, CCR7. Interestingly, in naïve animals, α4β7 expression was associated with increased NK cell activation and, on CD16+ NK cells, delineated a unique dual-function cytotoxic-CD107a+/gamma interferon (IFN-γ)-secreting population. However, while SIV infection increased CD107a expression on stimulated CD56+ NK cells, α4β7+ and α4β7− NK cells were affected similarly. These findings suggest that SIV infection redirects NK cells away from the lymph nodes to the gut mucosae but alters NK cell function independent of trafficking repertoires.
Human peripheral blood contains two primary subsets of natural killer (NK) cells—a major CD16+ CD56dim subset and a minor CD16− CD56bright subset. We have defined subsets of rhesus macaque (Macaca mulatta) NK cells and found that, similarly, macaque peripheral blood is dominated by a CD16+ CD56− subset but contains two minor CD16− CD56+ and CD16− CD56− subpopulations (34). As in humans, macaque CD16− CD56+ NK cells are the primary producers of gamma interferon (IFN-γ) and express cell surface markers such as CCR7 and CD62L that mediate homing to lymph nodes, whereas CD16+ CD56− NK cells do not express CCR7 or CD62L and primarily mediate cytolytic functions (7, 12, 30, 34). In both humans and macaques, the distribution of NK subsets in peripheral blood is distinct from that observed in lymph nodes and mucosal tissues, where NK cells are primarily CD56+ (9, 12, 30, 35).
NK cells are important for the control of multiple viral infections, and increasing evidence suggests that NK cells play a significant role in controlling human immunodeficiency virus (HIV) infection (3, 5, 13, 14, 19, 21, 22, 24, 33), as well as simian immunodeficiency virus (SIV) infection of rhesus macaques and sooty mangabeys (6, 16, 26). HIV and SIV primarily replicate in the gut mucosa (18), and although we and others have demonstrated the presence of NK cells in the gastrointestinal tracts of both humans and rhesus macaques (8, 9, 25, 30), the nature of these NK cells is still poorly understood. Interestingly, the integrin α4β7, which directs lymphocyte trafficking to the gut (4), has been shown to be expressed on peripheral blood NK cells in humans and rhesus macaques (11, 27). This finding suggests that the gut mucosa is a site of active NK cell trafficking.
Despite the importance of gut-associated lymphoid tissue in HIV/SIV pathogenesis, little is known about the effects of infection on NK cell homing to these tissues. In order to address this deficit, a total of 47 Indian rhesus macaques were studied, 27 of which were SIV naïve and 20 infected with either SIVmac239 (5) or SIVmac251 (15) for more than 150 days (mean duration of infection, 293 days). All animals were housed at the New England Primate Research Center and maintained in accordance with the guidelines of the Committee on Animals of the Harvard Medical School and the Guide for the Care and Use of Laboratory Animals (23a).
PBMC isolation and polychromatic flow cytometry staining were carried out using protocols described previously for our laboratory (29, 31); the antibodies used are listed in Table 1. NK cells were defined as CD3− CD8α+ NKG2A+ (30, 34), and CD16 and CD56 expression were used to delineate three primary subsets: CD56− CD16+ (CD16+), the dominant subset; CD56+ CD16− (CD56+); and CD56− CD16− (double negative [DN]) (Fig. 1 A). The results of polychromatic flow cytometry analyses demonstrated that α4β7 was expressed at the highest levels on CD16+ NK cells and that, while expression on this subset was not altered during SIV infection, α4β7 was significantly upregulated on both CD56+ and DN NK cells in SIV-infected animals (Fig. 1B and C). Interestingly, CCR7, which is expressed only on the CD56+ and DN NK cell subsets in macaques (30, 34), was concomitantly downregulated on these subsets of NK cells during chronic SIV infection (Fig. 1B). The relationship between the two markers delineated a dichotomous expression pattern between naïve and SIV-infected macaques (Fig. 1D). This dramatic shift in CD56+ and DN NK cell trafficking repertoires is likely indicative of increased homing of these NK subsets to the gut coupled to decreased homing to lymph nodes. Also, as shown in Fig. 1E, the absolute numbers of both CD16+ and DN NK cells increased during chronic SIV infection, resulting in increased absolute numbers of gut-homing α4β7+ cells in both subsets. Interestingly, while the absolute numbers of all CD56+ NK cells tended to decrease during chronic SIV infection, the absolute numbers of the α4β7+ CD56+ NK cell subset increased slightly (Fig. 1E, middle panel), further suggesting that multiple subsets of α4β7+ NK cells increase during chronic SIV infection.
TABLE 1.
Antibodies used in polychromatic flow cytometry analyses
| Antibody | Clone | Fluorochromec | Manufacturer |
|---|---|---|---|
| Anti-α4β7 | A4B7 | APC | NIH NPRRa |
| Anti-CCR7 | 150503 | Alexa700b | R&D Systems (Minneapolis, MN) |
| Anti-CD3 | SP34.2 | APC-Cy7 | BD Biosciences (La Jolla, CA) |
| Anti-CD8α | T8/7Pt-3F9 | QDot 605 | NIH NPRR |
| Anti-CD8α | SK1 | APC-Cy7 | BD Biosciences |
| Anti-CD16 | 3G8 | Alexa700, PE, FITC | BD Biosciences |
| Anti-CD56 | NCAM16.2 | PE-Cy7 | BD Biosciences |
| Anti-CD69 | TP1.55.3 | PE-Texas Red | Beckman Coulter (Fullerton, CA) |
| Anti-CD107a | H4A3 | PerCP-Cy5.5 | BD Biosciences |
| Anti-IFN-γ | B27 | FITC | Invitrogen (Carlsbad, CA) |
| Anti-NKG2A | Z199 | Pacific Blueb | Beckman Coulter |
NIH Nonhuman Primate Reagent Resource.
In-house custom conjugate.
APC, allophycocyanin; FITC, fluorescein isothiocyanate; PE, phycoerythrin; PerCP, peridinin chlorophyll protein.
FIG. 1.
Comparison of α4β7 expression on NK cell subsets in naïve and SIV-infected macaques. (A) Macaque NK cell subsets were defined as CD3− CD8α+ NKG2A+ (30, 34) and then further delineated into CD56+, CD16+, and DN subsets. (B) Representative flow cytometry plots of α4β7 and CCR7 expression on NK cell subsets in naïve and SIV-infected macaques. (C) Percentages of α4β7+ cells above the background level were compared between naïve and SIV-infected macaques for CD56+, CD16+, and DN NK subsets. (D) Relationships between α4β7 and CCR7 expression on CD56+ and DN NK cells in naïve and SIV-infected macaques. (E) Absolute numbers of total circulating NK cells were determined by using a bead-based flow cytometric assay as described previously (29, 30), and α4β7+ NK cell subset counts were extrapolated using these data combined with NK cell frequency data determined by polychromatic flow cytometry (panel A). Horizontal bars indicate median values for 20 to 27 animals. Student's t tests were used to compare naive and SIV-infected animal groups; P values of >0.05 are considered statistically significant.
Plasma viral loads were also determined for infected animals (range, 30 to 6,500,000 copy equivalents/ml), as described previously (10), but we found no correlation with either α4β7 or CCR7 expression (data not shown). However, even in infected animals with low levels of plasma viremia (i.e., <1,000 copies/ml), α4β7 expression was similar to that in animals with high viremia. This finding suggests that increased NK cell homing to the gut may occur even in instances of low-level viral replication.
We next examined whether α4β7+ NK cells were functionally different from their α4β7− counterparts in either naïve or SIV-infected macaques. We analyzed IFN-γ production and CD107a degranulation, as a marker for cytotoxicity, in a dual-function-intracellular-cytokine-staining assay by stimulating NK cells with major histocompatibility complex (MHC)-devoid 721.221 cells using protocols optimized in our laboratory (15, 30). In response to stimulation, CD16+ NK cells upregulated CD107a, indicative of a more cytotoxic phenotype (Fig. 2B). However, we also found that, in many animals, a subset of CD16+ NK cells secreted IFN-γ; these were found almost exclusively among α4β7+ cells (Fig. 2A). Moreover, as indicated by the results of multifunction analysis (SPICE 4.2 software; Mario Roederer, NIH), IFN-γ-secreting CD16+ NK cells were not only α4β7+ but were mostly dual function, as indicated by their coexpression of CD107a (Fig. 2C), and this functional profile was present in both naïve and SIV-infected macaques. The dominant response of CD56+ NK cells to stimulation was IFN-γ secretion, and interestingly, α4β7+ CD56+ NK cells in naïve animals (although rare) secreted IFN-γ at statistically higher frequencies than their α4β7− counterparts (P = 0.0015, Wilcoxon matched pairs test) (Fig. 2A). Furthermore, although CD56+ NK cells had low CD107a expression in naïve animals, this expression was significantly upregulated during chronic SIV infection (Fig. 2B). This expansion was most dramatic in monofunction CD107a+ degranulating cells but also occurred in dual-function IFN-γ-secreting cells (Fig. 2C). In infected animals, α4β7+ and α4β7− CD56+ NK cells had virtually the same functional profiles, suggesting that the expansion of CD107a+ cells was SIV induced but occurred independently of gut-homing potential. DN NK cells were hyperresponsive to 721.221 cell stimulation, as manifested by high levels of CD107a expression and moderate levels of IFN-γ secretion (Fig. 2A and B). When the DN NK cells were examined for dual functionality, we observed that, like CD16+ NK cells, most of the IFN-γ-secreting cells expressed CD107a, indicative of a dual-function phenotype (Fig. 2C). Interestingly, however, α4β7+ and α4β7− DN NK cells had virtually identical profiles in both naïve and SIV-infected macaques, with only a modest but not significant reduction in the frequency of dual-function cells. The fact that the DN NK subset expressed low levels of both CCR7 and α4β7 and had a high degree of both IFN-γ secretion and CD107a upregulation (even more so than the classical CD16+ effector population) suggests the possibility that the DN subset may be a less differentiated population than the other NK cell subsets. However, additional studies are necessary to better define the ontogeny of these macaque NK subsets and the in vivo function of the DN subset, especially with regard to potential cytotoxic function.
FIG. 2.
Function profiles of α4β7+ and α4β7− NK cell subsets in naïve and SIV-infected macaques. Enriched NK cells were stimulated with 721.221 cells, and IFN-γ production (A) and CD107a expression (B) were measured on α4β7+ and α4β7− NK cell subsets in naïve and SIV-infected macaques. The monofunction profile of each subset was determined by expressing each response as a proportion of the total cell subset. Horizontal bars indicate median values for 10 to 12 animals. Blue asterisks indicate statistically significant differences between α4β7+ and α4β7− NK cell subsets in naïve animals and red asterisks indicate statistically significant differences between naïve and SIV-infected macaques using the Mann-Whitney U test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (C) Multiparametric analyses were performed with SPICE 4.2 software (M. Roederer, NIH), and the pie charts represent the functional repertoires of all responding cells (nonresponsive cells are excluded for these analyses). Mean values for 10 to 12 animals are shown. Tables show the results of one-sided permutation tests comparing each of the pies as calculated by SPICE; P values of <0.05 are considered significant and are highlighted in yellow.
Interestingly, CD69 was expressed at the highest levels on CD16+ NK cells and was expressed at significantly higher levels on α4β7+ NK cells than on their α4β7− counterparts (Fig. 3). These data, combined with the observation that CD69 is globally upregulated on NK cells during chronic SIV infection (30), suggest that α4β7 expression is closely associated with NK cell activation. This is consistent with previous observations in both humans and rhesus macaques showing that α4β7 is upregulated on NK cells with ex vivo interleukin-2 (IL-2) stimulation (27, 28) and that decreased CCR7 expression is associated with increased NK cell activation (17, 20).
FIG. 3.
Increased expression of the activation marker CD69 on α4β7+ NK cells and during chronic SIV infection. Percentages of CD69 expression above background staining were measured on α4β7+ and α4β7− NK cell subsets in naïve and SIV-infected macaques. Horizontal bars indicate median values. Differences between α4β7+ and α4β7− NK cell subsets were analyzed using a Wilcoxon matched-pairs test (black asterisks), and comparisons between naïve and SIV-infected macaques were performed using a Mann-Whitney U test (red asterisks). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Herein we demonstrate independent but overlapping features of macaque NK cell subsets: (i) NK cells in SIV-infected animals display changes in phenotypic markers that suggest a shift in trafficking from the lymph nodes to the gut mucosa; (ii) NK cell subsets can possess both cytotoxic and cytokine-secreting functions that can occur simultaneously—particularly notable with the identification of α4β7+ gut-homing dual-function CD16+ NK cells, a finding that challenges the conventional wisdom that CD16+ NK cells mediate only effector functions; and (iii) NK cell subsets have an inherent plasticity that allows the expansion of cytotoxic features during chronic SIV infection. Interestingly, however, our data suggest that these two phenomena occur independently. Perturbations in NK cell function have been documented both in HIV and SIV infections (1-3, 6, 13, 16, 24), and our findings of increased monofunction and dual-function CD107a+ degranulating CD56+ NK cells are consistent with these observations. Furthermore, because HIV/SIV replicate primarily in CD4+ T lymphocytes found in the gut mucosa (18), increased trafficking of NK cells to the gut could represent a physiologic mechanism of modulating innate immune responses to the dominant site of viral replication. Also, although the absolute increase in α4β7+ CD56+ and DN NK cells in SIV-infected animals is relatively small compared to the size of the dominant population of α4β7+ CD16+ NK cells, the fact that these CD16− NK cells have a functional repertoire that is distinct from the repertoire of CD16+ NK cells suggests that the shift in NK cell trafficking may have consequences that are disproportionate to their frequencies. However, additional studies of mucosal tissues will be required to confirm the hypothesis that increased expression of α4β7 on NK cells from SIV-infected macaques enhances NK cell trafficking to the gut mucosa.
While the exact mechanisms responsible for increased numbers of circulating α4β7+ NK cells remain unknown, they could involve one or more of the following: (i) an overall shift in trafficking of preexisting α4β7+ NK cells to gut mucosa, resulting in increased numbers of α4β7+ NK cells in the blood; (ii) upregulation of α4β7 on previously α4β7− differentiated NK cells by retinoic acid or dendritic cell imprinting as has been observed for T cells (23, 32); and/or (iii) increased expression of α4β7 as a result of imprinting during NK cell differentiation. Regardless of the mechanism, because gut-homing CD16+ NK cells had more dual-function cells than their α4β7− counterparts and CD56+ NK cells had increased cytotoxicity coupled to increased α4β7 expression, the result would be greater numbers of monofunction cytotoxic or dual-function cells trafficking to the gut during chronic SIV infection. These data offer new insights into the role of innate immune responses in the control of mucosal SIV replication and raise the possibility that modulation of NK cells may affect future vaccine strategies and/or immunologic therapies for HIV/SIV infection.
Acknowledgments
We thank Michelle Connole, Fay E. Wong, and Yi Yu for expert technical assistance; Angela Carville and Elaine Roberts for dedicated animal care; and Jeff Lifson, Michael Piatak, Jr., and Yuan Li of the Quantitative Molecular Diagnostics Core of the AIDS and Cancer Virus Program, SAIC Frederick, Inc., NCI Frederick, for plasma SIV RNA determinations.
This research was supported by NIH grants AI062412, AI071306, and RR00168, as well as a CHAVI/HVTN Early Career Investigator award, grant number U19 AI 067854-04, to R.K.R.
Footnotes
Published ahead of print on 16 June 2010.
REFERENCES
- 1.Alter, G., M. P. Martin, N. Teigen, W. H. Carr, T. J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, C. Brander, J. D. Lifson, T. M. Allen, M. Carrington, and M. Altfeld. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204:3027-3036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Alter, G., N. Teigen, R. Ahern, H. Streeck, A. Meier, E. S. Rosenberg, and M. Altfeld. 2007. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 195:1452-1460. [DOI] [PubMed] [Google Scholar]
- 3.Alter, G., N. Teigen, B. T. Davis, M. M. Addo, T. J. Suscovich, M. T. Waring, H. Streeck, M. N. Johnston, K. D. Staller, M. T. Zaman, X. G. Yu, M. Lichterfeld, N. Basgoz, E. S. Rosenberg, and M. Altfeld. 2005. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106:3366-3369. [DOI] [PubMed] [Google Scholar]
- 4.Berlin, C., E. L. Berg, M. J. Briskin, D. A. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, and E. C. Butcher. 1993. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185-195. [DOI] [PubMed] [Google Scholar]
- 5.Bonaparte, M. I., and E. Barker. 2004. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104:2087-2094. [DOI] [PubMed] [Google Scholar]
- 6.Bostik, P., J. Kobkitjaroen, W. Tang, F. Villinger, L. E. Pereira, D. M. Little, S. T. Stephenson, M. Bouzyk, and A. A. Ansari. 2009. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J. Immunol. 182:3638-3649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Campbell, J. J., S. Qin, D. Unutmaz, D. Soler, K. E. Murphy, M. R. Hodge, L. Wu, and E. C. Butcher. 2001. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166:6477-6482. [DOI] [PubMed] [Google Scholar]
- 8.Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722-725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chinen, H., K. Matsuoka, T. Sato, N. Kamada, S. Okamoto, T. Hisamatsu, T. Kobayashi, H. Hasegawa, A. Sugita, F. Kinjo, J. Fujita, and T. Hibi. 2007. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology 133:559-573. [DOI] [PubMed] [Google Scholar]
- 10.Cline, A. N., J. W. Bess, M. Piatak, Jr., and J. D. Lifson. 2005. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34:303-312. [DOI] [PubMed] [Google Scholar]
- 11.Erle, D. J., M. J. Briskin, E. C. Butcher, A. Garcia-Pardo, A. I. Lazarovits, and M. Tidswell. 1994. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J. Immunol. 153:517-528. [PubMed] [Google Scholar]
- 12.Fehniger, T. A., M. A. Cooper, G. J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M. A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-3057. [DOI] [PubMed] [Google Scholar]
- 13.Fehniger, T. A., G. Herbein, H. Yu, M. I. Para, Z. P. Bernstein, W. A. O'Brien, and M. A. Caligiuri. 1998. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161:6433-6438. [PubMed] [Google Scholar]
- 14.Fogli, M., D. Mavilio, E. Brunetta, S. Varchetta, K. Ata, G. Roby, C. Kovacs, D. Follmann, D. Pende, J. Ward, E. Barker, E. Marcenaro, A. Moretta, and A. S. Fauci. 2008. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 4:e1000101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gauduin, M. C., A. Kaur, S. Ahmad, T. Yilma, J. D. Lifson, and R. P. Johnson. 2004. Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques. J. Immunol. Methods 288:61-79. [DOI] [PubMed] [Google Scholar]
- 16.Giavedoni, L. D., M. C. Velasquillo, L. M. Parodi, G. B. Hubbard, and V. L. Hodara. 2000. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J. Virol. 74:1648-1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Giuliani, M., J. Giron-Michel, S. Negrini, P. Vacca, D. Durali, A. Caignard, C. Le Bousse-Kerdiles, S. Chouaib, A. Devocelle, R. Bahri, A. Durrbach, Y. Taoufik, S. Ferrini, M. Croce, M. C. Mingari, L. Moretta, and B. Azzarone. 2008. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS One 3:e2241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Haase, A. T. 2010. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464:217-223. [DOI] [PubMed] [Google Scholar]
- 19.Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8:259-268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mailliard, R. B., S. M. Alber, H. Shen, S. C. Watkins, J. M. Kirkwood, R. B. Herberman, and P. Kalinski. 2005. IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202:941-953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, M. Wilson, S. J. O'Brien, and M. Carrington. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434. [DOI] [PubMed] [Google Scholar]
- 22.Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, J. J. Goedert, S. Buchbinder, G. D. Kirk, A. Telenti, M. Connors, S. J. O'Brien, B. D. Walker, P. Parham, S. G. Deeks, D. W. McVicar, and M. Carrington. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mora, J. R., M. R. Bono, N. Manjunath, W. Weninger, L. L. Cavanagh, M. Rosemblatt, and U. H. Von Andrian. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424:88-93. [DOI] [PubMed] [Google Scholar]
- 23a.National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
- 24.O'Connor, G. M., A. Holmes, F. Mulcahy, and C. M. Gardiner. 2007. Natural killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin. Immunol. 124:277-283. [DOI] [PubMed] [Google Scholar]
- 25.Pang, G., A. Buret, R. T. Batey, Q. Y. Chen, L. Couch, A. Cripps, and R. Clancy. 1993. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa. Immunology 79:498-505. [PMC free article] [PubMed] [Google Scholar]
- 26.Pereira, L. E., R. P. Johnson, and A. A. Ansari. 2008. Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell. Immunol. 254:10-19. [DOI] [PubMed] [Google Scholar]
- 27.Pereira, L. E., N. Onlamoon, X. Wang, R. Wang, J. Li, K. A. Reimann, F. Villinger, K. Pattanapanyasat, K. Mori, and A. A. Ansari. 2009. Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody. Cell. Immunol. 259:165-176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Perez-Villar, J. J., J. M. Zapata, I. Melero, A. Postigo, E. Sanchez-Madrid, and M. Lopez-Botet. 1996. Expression and function of alpha 4/beta 7 integrin on human natural killer cells. Immunology 89:96-104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Reeves, R. K., J. Gillis, F. E. Wong, and R. P. Johnson. 2009. Vaccination with SIVmac239deltanef activates CD4+ T cells in the absence of CD4+ T cell loss. J. Med. Primatol. 38(Suppl. 1):8-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Reeves, R. K., J. Gillis, F. E. Wong, Y. Yu, M. Connole, and R. P. Johnson. 2010. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115:4439-4446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Salisch, N. C., D. E. Kaufmann, A. S. Awad, R. K. Reeves, D. P. Tighe, Y. Li, M. Piatak, Jr., J. D. Lifson, D. T. Evans, F. Pereyra, G. J. Freeman, and R. P. Johnson. 2010. Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1. J. Immunol. 184:476-487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Saurer, L., K. C. McCullough, and A. Summerfield. 2007. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J. Immunol. 179:3504-3514. [DOI] [PubMed] [Google Scholar]
- 33.Ward, J., M. Bonaparte, J. Sacks, J. Guterman, M. Fogli, D. Mavilio, and E. Barker. 2007. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 110:1207-1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Webster, R. L., and R. P. Johnson. 2005. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115:206-214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wira, C. R., J. V. Fahey, C. L. Sentman, P. A. Pioli, and L. Shen. 2005. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206:306-335. [DOI] [PubMed] [Google Scholar]



